Clinical Trial Update: Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Topical YR001 Ointment in adults with mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• YR001 Ointment

Snippet

Sponsor: Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED